The gene expression of p53 in BCC was downregulated in response to PRF treatment at all three time points, but only statistically significantly decreased on the fourth day, with lower levels of gene expression in the low RCF PRF-treated group (A–C). Here, TP53 is linked to skin basal cell carcinoma.